Earnings calendar/KYTX
Kyverna Therapeutics, Inc. (KYTX)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Next report
Nov 11, 2026
Expected from filing cadence
EPS target
$-0.68
Estimates not sourced
Revenue target
—
Estimates not sourced
Trailing EPS (avg 4Q)
$-0.73
Beat rate last 4: 100%
Latest EPS YoY
+35.1%
vs 2025-08-12
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 12, 2026
EPS beat
EPS actual / est
$-0.63 / $-0.68
+7.1%
Revenue actual / est
— / —
—
Result
Target reached
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/11/2026upcoming | $-0.68 | Pending | — | — | Pending | — |
| 8/12/2026 | $-0.68 | $-0.63 | +7.1% | — | Pending | — |
| 5/12/2026 | $-0.75 | $-0.66 | +12.0% | — | Pending | — |
| 4/1/2026upcoming | $-0.85 | Pending | — | — | Pending | — |
| 3/26/2026 | $-0.84 | $-0.80 | +5.3% | — | Pending | — |
| 11/12/2025 | $-0.97 | $-0.85 | +12.4% | — | Pending | — |
| 8/12/2025 | $-1.00 | $-0.97 | +3.0% | — | Pending | — |
| 5/13/2025 | $-1.21 | $-1.03 | +14.9% | — | Pending | — |
| 3/27/2025 | $-0.87 | $-0.88 | -1.1% | — | Pending | — |
| 11/13/2024 | $-0.77 | $-0.80 | -3.9% | — | Pending | — |
| 8/12/2024 | $-0.70 | $-0.67 | +4.3% | — | Pending | — |
| 5/14/2024 | $-0.88 | $-1.12 | -27.3% | — | Pending | — |
| 3/26/2024 | $-3.23 | $-26.86 | -731.6% | $3.8M | Pending | — |
| 2/8/2024 | $-3.23 | $-26.86 | -731.6% | — | Pending | — |
| 9/30/2023 | — | $-0.36 | — | — | Pending | — |
| 6/30/2023 | — | $-0.30 | — | — | Pending | — |
| 3/31/2023 | — | $-0.43 | — | — | Pending | — |
| 12/31/2022 | — | $-0.20 | — | — | $282,000 | — |